756 Pill: white, capsule/oblong, 24mm
The pill with imprint 756 (White, Capsule/Oblong, 24mm) has been identified as Temozolomide 250 mg and is used for Glioblastoma Multiforme, and Anaplastic Astrocytoma. It belongs to the drug class alkylating agents and is not a controlled substance.
Images for 756
Temozolomide
- Imprint
- 756
- Strength
- 250 mg
- Color
- White
- Size
- 24.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Alkylating agents
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Zydus Pharmaceuticals (USA) Inc.
- Manufacturer
- Cadila Healthcare Limited
- National Drug Code (NDC)
- 68382-0756
- Inactive Ingredients
-
alcohol,
ammonia,
lactose anhydrous,
butyl alcohol,
ferrosoferric oxide,
gelatin,
isopropyl alcohol,
potassium hydroxide,
propylene glycol,
shellac,
silicon dioxide,
sodium lauryl sulfate,
sodium starch glycolate type B potato,
stearic acid,
tartaric acid,
titanium dioxide,
water
Note: Inactive ingredients may vary.
Related images for "756"
Featured
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Reviews & ratings
More about temozolomide
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (10)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: alkylating agents
- En español
Patient resources
- Temozolomide oral/injection drug information
- Temozolomide (Intravenous) (Advanced Reading)
- Temozolomide (Oral) (Advanced Reading)
- Temozolomide Capsules
- Temozolomide Injection
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.